This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

6 High-Volume Stocks With Relative Strength

Cubist Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cubist Pharmaceuticals (CBST) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings. This stock is trading up 1.4% at $41.20 in recent trading.

Today's Volume: 859,000

Average Volume: 800,610

Volume % Change: 88%

>>5 Biotech Stocks Under $10 Set to Soar

Shares of CBST are moving modestly higher today after the company beat Wall Street expectations as sales for its lead drug Cubicin soared. Total revenue registered a 30% rise to $231 million, and Cubicin sales rose 20% to $212 million.

From a technical perspective, CBST is moving modestly higher here with above average volume, after the stock briefly traded below both its 50-day and 200-day moving averages. This move is now pushing CBST within range of triggering a near-term breakout trade. That trade will trigger once CBST takes out some near-term overhead resistance at $41.85 with high volume.

Traders should now look for long-biased trades once CBST sustains a move or close over $41.85 with volume that's near or above 800,610 shares. If we get that action soon, then CBST will have a great chance of re-testing and possibly taking out its next major overhead resistance levels at $43 to $44.95.
5 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ALGN $62.72 1.70%
CBST $101.94 0.14%
SNDK $58.26 -3.20%
SLM $9.88 0.36%
AAPL $125.42 0.72%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.12 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs